ClearanceBrief
Recall Z-2441-2010 ยท JJE Analyzer, Chemistry (Photometric, Discrete), For Clinical Use

Beckman Coulter Inc.

Unicel Synchron Clinical Systems Closed Tube Aliquotter (CTA) for Synchron LXi 725, Part Number: 388982, Domestic; 389695, International The UniCel Synchron Clinical Systems are fully automated, computer controlled clinical chemistry analyzers designed for the in vitro determination of a variety of general chemistries, therapeutic drugs, and other chemistries. Analysis can be performed on serum, p

DateSep 20, 2010 (initiated Jan 18, 2010)
StatusTerminated
ReasonThe recall was initiated due to " A loose Aliquot Probe tube fitting in the Closed Tube Aliquotter (CTA), may result in erroneous Access immunoassay results or Synchron chemistry results". This may result in dilution of the sample with Wash Buffer; patient results can potentially be affected for Access immunoassays or Synchron chemistries. Access Quality Control may also be affected if run throug
Root causeOther
ActionBeckman Coulter sent an "URGENT: PRODUCT CORRECTIVE ACTION" letter dated January 18, 2010, to all affected customers. The letter provided the customer with an explanation of the problem identified, the affected product, and instructions for the customer. The letter requested customers complete the following actions for : (1) CTA Aliquot Probe Inspection and Maintenance: a. Check daily for signs of leaks or damage to the tube fitting by looking and feeling for liquid at the fitting, the end of the probe and the surrounding areas; b. The CTA Aliquot Probe tube fitting should be checked to en
Quantity672 units for both systems
DistributionWorldwide Distribution - USA: including the states of AK, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, VA, WA, WI, AND WV and the country of Canada.
FDA recordOpen on fda.gov

510(k) clearances named in this recall

K023049SYNCHRON LX I 725 CLINICAL SYSTEM
Beckman Coulter, Inc., Oct 4, 2002